Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
245 studies found for:    cardiac CT OR CAT scan OR coronary artery scan | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
1 Recruiting Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer
Conditions: Adenosquamous Lung Carcinoma;   Bronchioloalveolar Carcinoma;   Large Cell Lung Carcinoma;   Lung Adenocarcinoma;   Squamous Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Radiation: External Beam Radiation Therapy;   Radiation: Image-Guided Adaptive Radiation Therapy;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis
2 Recruiting Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Gastrin-Producing Neuroendocrine Tumor;   Pancreatic Glucagonoma;   Pancreatic Insulinoma;   Pancreatic Polypeptide Tumor;   Recurrent Pancreatic Neuroendocrine Carcinoma;   Somatostatin-Producing Neuroendocrine Tumor
Interventions: Biological: Ziv-Aflibercept;   Radiation: Computed Tomography Perfusion Imaging;   Other: Laboratory Biomarker Analysis
3 Unknown  The Addition of Cardiac CT to Exercise Treadmill Testing in the Evaluation of Angina
Condition: Angina
Intervention:
4 Recruiting Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma;   Stage IV Renal Cell Cancer
Interventions: Drug: Entinostat;   Biological: Aldesleukin;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography
5 Recruiting Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer
Conditions: Malignant Neoplasm;   Metastatic Malignant Neoplasm to the Bone
Interventions: Radiation: virtual non-calcium dual-energy computed tomography;   Radiation: computed tomography
6 Recruiting Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Have Undergone Stem Cell Transplant
Conditions: Cancer Survivor;   Diabetes Mellitus;   Hypertension
Interventions: Procedure: computed tomography;   Other: cytology specimen collection procedure;   Other: laboratory biomarker analysis;   Other: questionnaire administration
7 Recruiting Dual Energy CT for Ischemia Determination Compared to "Gold Standard" Non-Invasive and Invasive Techniques
Condition: Ischemia
Intervention: Procedure: CT and stress test
8 Recruiting Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
Conditions: Recurrent Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Follicular Carcinoma;   Stage IVA Thyroid Gland Papillary Carcinoma;   Stage IVB Thyroid Gland Follicular Carcinoma;   Stage IVB Thyroid Gland Papillary Carcinoma;   Stage IVC Thyroid Gland Follicular Carcinoma;   Stage IVC Thyroid Gland Papillary Carcinoma
Interventions: Radiation: Iodine I 124;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Drug: Trametinib;   Radiation: Iodine I-131;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
9 Recruiting 18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
Conditions: Malignant Primary Brain Neoplasm;   Metastatic Malignant Neoplasm to the Brain;   Recurrent Adult Brain Neoplasm
Interventions: Radiation: Fluorothymidine F-18;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography
10 Recruiting 18F-DOPA-PET in Planning Surgery in Patients With Gliomas
Conditions: Acoustic Schwannoma;   Adult Anaplastic (Malignant) Meningioma;   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Choroid Plexus Neoplasm;   Adult Craniopharyngioma;   Adult Diffuse Astrocytoma;   Adult Ependymoblastoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Grade I Meningioma;   Adult Grade II Meningioma;   Adult Medulloblastoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Papillary Meningioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Pineoblastoma;   Adult Pineocytoma;   Adult Primary Melanocytic Lesion of Meninges;   Adult Subependymal Giant Cell Astrocytoma;   Adult Subependymoma;   Childhood Cerebellar Anaplastic Astrocytoma;   Childhood Cerebellar Astrocytoma;   Childhood Cerebral Anaplastic Astrocytoma;   Childhood Cerebral Astrocytoma;   Childhood Choroid Plexus Neoplasm;   Childhood Craniopharyngioma;   Childhood Ependymoblastoma;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood Infratentorial Ependymoma;   Childhood Mixed Glioma;   Childhood Supratentorial Ependymoma;   Malignant Adult Intracranial Hemangiopericytoma;   Medulloepithelioma;   Newly Diagnosed Childhood Ependymoma;   Recurrent Adult Brain Neoplasm;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Pleomorphic Xanthoastrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligoastrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Diffuse Astrocytoma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Gemistocytic Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Medulloblastoma;   Untreated Childhood Oligoastrocytoma;   Untreated Childhood Oligodendroglioma;   Untreated Childhood Pilocytic Astrocytoma;   Untreated Childhood Pilomyxoid Astrocytoma;   Untreated Childhood Pineoblastoma;   Untreated Childhood Pleomorphic Xanthoastrocytoma;   Untreated Childhood Protoplasmic Astrocytoma;   Untreated Childhood Subependymal Giant Cell Astrocytoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor;   Untreated Childhood Visual Pathway Glioma
Interventions: Drug: Fluorine F 18 Fluorodopa;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Procedure: Diffusion Weighted Imaging;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Biopsy;   Other: Laboratory Biomarker Analysis
11 Recruiting PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Proton Beam Radiation Therapy;   Drug: Carboplatin;   Drug: Paclitaxel
12 Recruiting 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
Conditions: Adult Anaplastic (Malignant) Meningioma;   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Brain Stem Glioma;   Adult Choroid Plexus Neoplasm;   Adult Ependymoblastoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Medulloblastoma;   Adult Mixed Glioma;   Adult Papillary Meningioma;   Adult Pineal Gland Astrocytoma;   Adult Pineoblastoma;   Adult Primary Melanocytic Lesion of Meninges;   Adult Supratentorial Primitive Neuroectodermal Tumor
Interventions: Drug: Fluorine F 18 Fluorodopa;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Diffusion Weighted Imaging;   Radiation: Intensity-Modulated Radiation Therapy;   Drug: Temozolomide;   Other: Quality-of-Life Assessment
13 Recruiting Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer
Condition: Recurrent Prostate Cancer
Interventions: Procedure: computed tomography;   Procedure: bone scan;   Procedure: 3-Tesla magnetic resonance imaging;   Procedure: diffusion-weighted magnetic resonance imaging;   Radiation: fluorine F 18 sodium fluoride;   Procedure: positron emission tomography;   Other: laboratory biomarker analysis
14 Recruiting Screening for Age-Related Skeletal Muscle Dysfunction
Condition: Sarcopenia
Interventions: Radiation: DXA scanning;   Radiation: CT imaging
15 Recruiting Gallium Ga 68-Edotreotide PET/CT Compared With Indium In 111 Pentetreotide Plus Contrast-Enhanced CT (or MRI) in Diagnosing Patients With Neuroendocrine Tumors and Other Somatostatin Receptor Positive Tumors
Conditions: Adult Medulloblastoma;   Childhood Medulloblastoma;   Neuroblastoma;   Neuroendocrine Tumor;   Somatostatinoma
Interventions: Radiation: gallium Ga 68-edotreotide;   Procedure: positron emission tomography/computed tomography;   Radiation: indium In 111 pentetreotide;   Procedure: computed tomography;   Procedure: contrast-enhanced magnetic resonance imaging
16 Recruiting High Risk Endometrial Cancer and Lymph Nodes Metastasis
Condition: Gynecologic Cancer
Interventions: Procedure: PET/CT Scan;   Procedure: Sentinel Lymph Node Mapping
17 Recruiting Pioglitazone for Lung Cancer Chemoprevention
Conditions: Lung Cancer;   Endobronchial Dysplasia
Interventions: Procedure: fluorescence bronchoscopy;   Procedure: quantitative high resolution CT scan;   Drug: PIOGLITAZONE VS. PLACEBO 30 mg
18 Recruiting Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes
Conditions: Chronic Obstructive Pulmonary Disease;   HIV;   Emphysema
Interventions: Procedure: blood draw;   Procedure: questionnaires;   Procedure: Lung function testing;   Procedure: Six-Minute walk test;   Radiation: Quantitative CT scans;   Procedure: Nasal secretion and cell collection;   Procedure: Echocardiogram;   Procedure: Glycocalyx
19 Recruiting 18F-FMAU PET/CT in Imaging Patients With Advanced Cancers
Condition: Malignant Neoplasm
Interventions: Radiation: fluorine F 18 d-FMAU;   Procedure: positron emission tomography;   Procedure: computed tomography
20 Recruiting PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer
Conditions: HER2-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Other: laboratory biomarker analysis;   Other: pharmacological study;   Other: questionnaire administration;   Radiation: fluorine F 18-clevudine;   Procedure: positron emission tomography/computed tomography

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years